Loading...

Calliditas Therapeutics AB (publ)

CALTNASDAQ
Healthcare
Biotechnology
$40.000
$-0.04(-0.10%)
U.S. Market opens in 10h 56m

CALT News Today: Stay Updated with the Latest Calliditas Therapeutics AB (publ) News in Real Time

Find CALT news now at Meyka AI. Stay informed with the latest Calliditas Therapeutics AB (publ) stocks updates, including price news, market analysis, and expert insights.

SRPT Maintained at Sell by H.C. Wainwright, April 2026
📅 in about 3 hours

SRPT Maintained at Sell by H.C. Wainwright, April 2026

H.C. Wainwright maintains Sell rating on SRPT, citing Roche decision impact on U.S. market prospects for Sarepta Therapeutics.

Read more
WHK.AX stock surges 33% on high volume in pre-market trading
📅 1 hour ago

WHK.AX stock surges 33% on high volume in pre-market trading

WhiteHawk Limited (WHK.AX) jumps 33.33% to A$0.008 with 10M shares traded in pre-market session on April 17, 2026.

Read more
ERCB.DE Stock Edges Down 0.39% as Earnings Loom on April 17
📅 3 hours ago

ERCB.DE Stock Edges Down 0.39% as Earnings Loom on April 17

ERCB.DE trades at €10.16 ahead of earnings. Meyka AI rates the stock B+ with a Buy recommendation. Technical analysis shows mixed signals.

Read more
NARA.CN Stock Plunges 32.6% on CNQ Exchange, Pangenomic Health Faces Steep Decline
📅 4 hours ago

NARA.CN Stock Plunges 32.6% on CNQ Exchange, Pangenomic Health Faces Steep Decline

NARA.CN stock drops 32.6% to C$0.32 on CNQ. Pangenomic Health Inc. faces significant losses amid trading volatility and weak financial metrics.

Read more
ERIC Stock Drops 1.17% Before Q1 2026 Earnings on April 17
📅 11 hours ago

ERIC Stock Drops 1.17% Before Q1 2026 Earnings on April 17

ERIC stock falls 1.17% to $11.87 ahead of Q1 2026 earnings announcement on April 17. Meyka AI rates the stock with a B+ grade.

Read more
ADXN.SW Stock Surges 8.5% on April 16, 2026 – Addex Therapeutics Gains
📅 11 hours ago

ADXN.SW Stock Surges 8.5% on April 16, 2026 – Addex Therapeutics Gains

ADXN.SW stock jumps 8.5% to CHF 0.051 on SIX. Addex Therapeutics gains amid biotech volatility and CNS drug pipeline developments.

Read more
GLUE Stock: CEO Markus Warmuth Sells 8,000 Shares April 14
📅 12 hours ago

GLUE Stock: CEO Markus Warmuth Sells 8,000 Shares April 14

Monte Rosa Therapeutics CEO Markus Warmuth sold 8,000 shares at $17.64 on April 14, 2026. SEC Form 4 filing details.

Read more
CHM.AX stock crashes 50% in after-hours trading on 16 Apr 2026
📅 14 hours ago

CHM.AX stock crashes 50% in after-hours trading on 16 Apr 2026

CHM.AX stock plummets 50% to A$0.001 in after-hours session. Chimeric Therapeutics faces steep decline amid biotech volatility.

Read more
5G7.F Stock Drops 12% in Pre-Market: KB Components AB Analysis
📅 15 hours ago

5G7.F Stock Drops 12% in Pre-Market: KB Components AB Analysis

5G7.F stock falls 12% to €3.59 in pre-market trading. KB Components AB faces pressure despite strong revenue growth and industrial sector demand.

Read more

CALT News FAQ